Anti-ELMO1 + ELMO2 antibody [EPR13567]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Recombinant Monoclonal ELMO2 antibody. Suitable for WB and reacts with Human, Recombinant fragment - Human samples. Cited in 3 publications.
View Alternative Names
CED12A, KIAA1834, ELMO2, Engulfment and cell motility protein 2, Protein ced-12 homolog A, hCed-12A, KIAA0281, ELMO1, Engulfment and cell motility protein 1, Protein ced-12 homolog
- WB
Supplier Data
Western blot - Anti-ELMO1 + ELMO2 antibody [EPR13567] (AB181234)
All lanes:
Western blot - Anti-ELMO1 + ELMO2 antibody [EPR13567] (ab181234) at 1/2000 dilution
Lane 1:
Jurkat cell lysate at 20 µg
Lane 2:
HeLa cell lysate at 20 µg
Lane 3:
Human fetal brain lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 83 kDa
false
- WB
Supplier Data
Western blot - Anti-ELMO1 + ELMO2 antibody [EPR13567] (AB181234)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-ELMO1 + ELMO2 antibody [EPR13567] (ab181234) at 1/2000 dilution
Lane 1:
ELMO2 Human Recombinant Protein
Lane 2:
ELMO1 Human Recombinant Protein
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 83 kDa
false
Exposure time: 20s
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ELMO1 and ELMO2 facilitate the regulation of cell migration phagocytosis and apoptosis. They are parts of a larger protein complex involving Dock180 and Rac1 contributing to the reorganization of the actin cytoskeleton. The ELMO-Dock180 complex acts as a critical mediator for the Rac signaling pathway affecting how cells respond to external signals that guide movement and cell survival.
Pathways
ELMO1 and ELMO2 participate in signaling pathways like the Rac1 pathway and the PI3K/Akt pathway. Through interactions with Rac1 these proteins regulate cytoskeletal rearrangements essential for various cellular processes including movement and immune cell function. ELMO1 and ELMO2 also connect with PI3K influencing the PI3K/Akt signaling cascade that is involved in cell growth and survival.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Cancers 14: PubMed36551595
2022
Applications
Unspecified application
Species
Unspecified reactive species
Biochimica et biophysica acta 1863:2892-2904 PubMed27627840
2016
Applications
Unspecified application
Species
Mouse
Molecular biology of the cell 26:2712-25 PubMed25995380
2015
Applications
Unspecified application
Species
Mouse
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com